中国卒中杂志 ›› 2025, Vol. 20 ›› Issue (2): 158-162.DOI: 10.3969/j.issn.1673-5765.2025.02.005

• 专题论坛 • 上一篇    下一篇

胆管细胞癌相关性缺血性卒中1例并文献复习

韦静雯,宋萍萍,丁燕,张玉生   

  1. 广州 510630 暨南大学附属第一医院神经内科
  • 收稿日期:2025-01-16 出版日期:2025-02-20 发布日期:2025-02-20
  • 通讯作者: 张玉生 757181750@qq.com
  • 基金资助:
    广东省自然科学基金面上项目(2020A1515011249)
    中央高校基本科研业务费专项资金资助(21620406)
    广州市科技计划项目(2023A03J0577;2023A04J1914)

Cholangiocarcinoma-Associated Ischemic Stroke: A Case Report and Literature Review

WEI Jingwen, SONG Pingping, DING Yan, ZHANG Yusheng   

  1. Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China
  • Received:2025-01-16 Online:2025-02-20 Published:2025-02-20
  • Contact: ZHANG Yusheng, E-mail: 757181750@qq.com

摘要: 恶性肿瘤可明显增加缺血性卒中的发生风险,而缺血性卒中会加重肿瘤患者病情,是患者非肿瘤性死亡的重要原因。肿瘤相关性缺血性卒中(cancer-associated ischemic stroke,CAIS)发病机制复杂,预后差。早期识别和综合管理CAIS对改善患者预后有重要意义。本文报道1例胆管细胞癌相关性缺血性卒中病例的诊治过程,并结合文献复习,阐述CAIS的发病机制、临床特征、治疗与预后,为临床提供借鉴。

关键词: 肿瘤相关性缺血性卒中; 胆管细胞癌; 特鲁索综合征; 高凝状态

Abstract: Malignant tumors can significantly increase the risk of ischemic stroke, and ischemic stroke can exacerbate the condition of tumor patients, making it an important cause of non-neoplastic deaths. The pathogenesis of cancer-associated ischemic stroke (CAIS) is complex, with a generally poor prognosis. Therefore, early identification and comprehensive management of CAIS are of great significance for improving the prognosis of patients. This article reported the diagnosis and treatment process of a case of cholangiocarcinoma-associated ischemic stroke. Combined with literature review, the pathogenesis, clinical characteristics, treatment, and prognosis of CAIS were expounded, providing a reference for clinical practice.

Key words: Cancer-associated ischemic stroke; Cholangiocarcinoma; Trousseau’s syndrome; Hypercoagulabale state

中图分类号: